SOCIETE DE PROMOTION PHARMACEUTIQUE DU MAGHREB S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 976.2 MAD | +5.99% |
|
+3.85% | -2.38% |
| Sales 2021 | 630M 62.25M | Sales 2022 | 705M 69.57M | Capitalization | 1.07B 105M |
|---|---|---|---|---|---|
| Net income 2021 | 69M 6.81M | Net income 2022 | 75M 7.41M | EV / Sales 2021 | 1.48 x |
| Net cash position 2021 | 205M 20.25M | Net cash position 2022 | 56.78M 5.61M | EV / Sales 2022 | 1.44 x |
| P/E ratio 2021 |
16.5
x | P/E ratio 2022 |
14.2
x | Employees | - |
| Yield 2021 |
3.51% | Yield 2022 |
3.75% | Free-Float | 5.88% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +5.99% | ||
| 1 week | +3.85% | ||
| Current month | +3.30% | ||
| 1 month | +0.43% | ||
| 3 months | +3.30% | ||
| 6 months | -3.35% | ||
| Current year | -2.38% |
1 week
921.00
976.20
1 month
921.00976.20
Current year
921.001 008.00
1 year
921.001 110.00
3 years
800.001 226.00
5 years
690.001 226.00
10 years
634.001 690.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Said El Bouachi
DFI | Director of Finance/CFO | - | - |
Amine Alaoui
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ma’moun Araidah
CHM | Chairman | - | - |
Khalid Janahi
BRD | Director/Board Member | - | - |
Issam Maguiri
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 976.2 | +5.99% | 52 |
| 24-04-16 | 921 | -3.05% | 1 |
| 24-04-15 | 950 | +1.06% | 10 |
End-of-day quote Casablanca S.E., April 16, 2024
More quotes
Promopharm (Société de Promotion Pharmaceutique du Maghreb) specializes in manufacturing and marketing pharmaceutical, para-pharmaceutical, and cosmetic products. The group also offers subcontractor manufacturing services for pharmaceutical specialties for Moroccan and foreign laboratories. The group's activity is organized primarily around 2 areas:
- sales of drugs: products manufactured under its own name and under license;
- importing and sales of semi-finished products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -2.38% | 96.12M | |
| +20.40% | 44.1B | |
| +17.11% | 21.97B | |
| +8.10% | 13.27B | |
| +6.06% | 13.22B | |
| +35.95% | 11.36B | |
| -8.53% | 7.07B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.09% | 5.23B |
- Stock Market
- Equities
- PRO Stock
